Donald S. Kaufman

Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.

William U. Shipley, Kathryn Winter, Donald S. Kaufman et al. · Journal of Clinical Oncology · 1998 · 484 citations

Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233

Raymond H. Mak, Daniel Hunt, William U. Shipley et al. · Journal of Clinical Oncology · 2014 · 438 citations · Full text

Effects of ligand activation of peroxisome proliferator-activated receptor γ in human prostate cancer

Elisabetta Mueller, Matthew R. Smith, Pasha Sarraf et al. · Proceedings of the National Academy of Sciences · 2000 · 422 citations · Full text

Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience

Jason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley et al. · European Urology · 2011 · 422 citations

Urology, Selective Bladder Preservation, Surgical Oncology +7

Randomized Controlled Trial of Annual Zoledronic Acid to Prevent Gonadotropin-Releasing Hormone Agonist–Induced Bone Loss in Men With Prostate Cancer

M. Dror Michaelson, Donald S. Kaufman, Hang Lee et al. · Journal of Clinical Oncology · 2007 · 326 citations · Full text